Zubretsky Joseph M reported grant involving 16,735 shares of MOLINA HEALTHCARE, INC. at $387.21 for $6.48M on Mar 1, 2024

Grant
Form 4 code A. Grant, award, or other acquisition under Rule 16b-3(d).
President & CEO
President & CEO
Filed Nov 13, 2026

Facts from the filing

Form 4/A · Non-derivative, table I
Disclosed value
$6,479,959.35Shares × reported price
Shares traded
16,735Common Stock
Price per share
$387.21Reported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
366,687Direct
Trade date
Mar 1, 2024Grant
Filed
Nov 13, 2026, 5:39 PM ET987-day reporting delay
Accession
0001320929-26-000005Code A · Transaction 401151
How reported position traded is calculated

Calculated only for code-P purchases and code-S sales.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
Mar 1, 2024Tax withholding10,639$387.21−$4,119,527.19Trade 401150
2 transaction rows in this filing. Joint filers share the same rows.

This amendment is separate from the original filing. It may contain only changed rows. Read both SEC reports.

Filing warnings

Notes recorded with this filing
2 warnings
amended filingThis transaction comes from an amended Form 4 filing.
delayed filingThe filing was reported 987 calendar days after the transaction date.

MOH price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
MOH · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.

Return windows are pending. The first 7-day window is eligible on Nov 20, 2026. Values appear when the daily price refresh supplies a valid close for that window. Weekends, market holidays and missing prices can delay updates.

Pre-filing1mo ago1w ago1d ago
Returns since7d30d90d180d1y

Footnotes in full

F1: The original Form 4 filed on March 5, 2024 is being amended by this Form 4/A to correct an inadvertently overstated share amount for tax withholding. Because the shares withheld for taxes was overstated by 16,735 shares, the shareholdings of the Reporting Person as of March 1, 2024 was understated by the same amount of 16,735 shares. The accurate shareholdings of the Reporting Person as of March 1, 2024 was actually 366,687 shares as reflected on item 5 of this form. This 16,735 shares increase in the Reporting Person's shareholdings results in the Reporting Person's accurate total holdings as of March 1, 2026 of 373,465 shares, consisting of 274,450 shares held indirectly and 99,015 shares held directly. F2: Grant of restricted stock under the Issuer's 2019 Equity Incentive Plan.